Osteoprotegerin is also an independent predictor of coronary artery disease in asymptomatic type 2 diabetic patients with microalbuminuria[23] and is also predictive of the long-term outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention[24]. This evidence concerns the gene TNFRSF11B and ST Elevation Myocardial Infarction.